Profile data is unavailable for this security.
About the company
Siegfried Holding AG is a Switzerland-based life sciences company which is active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and sterile. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States, China, and Spain.
- Revenue in CHF (TTM)1.28bn
- Net income in CHF128.23m
- Incorporated1904
- Employees3.80k
- LocationSiegfried Holding AGUntere Bruehlstrasse 4ZOFINGEN 4800SwitzerlandCHE
- Phone+41 627461111
- Fax+41 627461102
- Websitehttps://www.siegfried.ch/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kalbe Farma Tbk PT | 1.75bn | 168.10m | 4.42bn | 12.99k | 25.88 | 3.62 | 20.65 | 2.53 | 65.89 | 65.89 | 684.23 | 471.50 | 1.13 | 2.88 | 5.94 | 2,410,624,000.00 | 11.05 | 12.50 | 14.27 | 15.48 | 37.20 | 41.21 | 9.79 | 11.26 | 2.47 | -- | 0.0415 | 50.53 | 5.24 | 7.64 | -18.20 | 2.40 | -3.00 | 3.58 |
| Hikma Pharmaceuticals Plc | 2.56bn | 241.46m | 4.74bn | 8.97k | 19.77 | 2.44 | 11.63 | 1.85 | 0.9688 | 0.9688 | 10.27 | 7.86 | 0.6374 | 1.77 | 3.38 | 255,666.10 | 6.13 | 8.19 | 8.47 | 11.30 | 47.40 | 50.29 | 9.61 | 13.77 | 0.9775 | 7.81 | 0.3568 | 36.71 | 14.22 | 6.73 | 1.06 | -7.59 | 7.97 | 14.03 |
| Richter Gedeon Vegyeszeti Gyar Nyrt | 1.94bn | 546.78m | 4.77bn | 11.60k | 8.59 | 1.67 | 7.19 | 2.46 | 1,248.46 | 1,248.46 | 4,419.54 | 6,425.20 | 0.5959 | 1.36 | 3.77 | 69,931,480.00 | 16.92 | 11.64 | 19.01 | 13.28 | 68.64 | 58.18 | 28.40 | 18.93 | 2.03 | -- | 0.0454 | 39.94 | 0.2993 | 12.57 | -6.05 | 35.06 | 15.59 | 33.94 |
| GlaxoSmithKline Pharmaceuticals Limited | 354.61m | 64.72m | 4.79bn | 3.21k | 74.10 | -- | 66.80 | 13.52 | 37.77 | 37.77 | 206.98 | -- | -- | -- | -- | 10,920,890.00 | -- | 11.01 | -- | 17.88 | 61.97 | 55.77 | 18.25 | 12.25 | -- | 490.08 | -- | 192.07 | 6.21 | 2.00 | -2.91 | 5.78 | -36.02 | 9.86 |
| Glenmark Pharmaceuticals Ltd | 1.22bn | -159.09m | 4.89bn | 14.99k | -- | -- | -- | 4.02 | -55.78 | -46.50 | 425.96 | -- | -- | -- | -- | 8,020,026.00 | -- | 1.02 | -- | 1.43 | 63.93 | 59.47 | -12.71 | 1.43 | -- | 1.78 | -- | 56.98 | 1.98 | 3.67 | -1,018.93 | -- | -5.89 | 4.56 |
| Beijing Tiantan Biological Products Corp | 636.63m | 151.57m | 4.97bn | 4.86k | 32.76 | 4.03 | -- | 7.80 | 0.6419 | 0.6419 | 2.70 | 5.22 | 0.3674 | 0.9077 | 222.80 | 1,097,335.00 | 11.86 | 11.71 | 17.11 | 16.50 | 53.54 | 49.39 | 32.28 | 27.71 | 3.23 | -- | 0.0074 | 16.67 | 21.57 | 12.06 | 25.99 | 16.85 | 29.67 | 38.97 |
| Rohto Pharmaceutical Co Ltd | 1.65bn | 180.41m | 5.00bn | 7.26k | 26.85 | 3.15 | 21.25 | 3.02 | 132.56 | 132.56 | 1,215.22 | 1,129.95 | 0.7642 | 2.21 | 4.37 | 38,300,730.00 | 8.42 | 8.54 | 11.70 | 11.79 | 57.76 | 58.59 | 11.02 | 10.30 | 1.27 | -- | 0.1513 | 19.39 | 13.48 | 8.09 | 17.28 | 25.85 | 5.20 | 18.61 |
| Beijing Tongrentang Co Ltd | 2.13bn | 203.41m | 5.16bn | 16.78k | 25.38 | 3.24 | -- | 2.42 | 1.24 | 1.24 | 13.02 | 9.72 | 0.5916 | 1.14 | 12.61 | 1,064,742.00 | 8.41 | 8.20 | 16.20 | 16.17 | 45.25 | 46.59 | 14.22 | 13.33 | 1.90 | -- | 0.186 | 30.93 | 16.19 | 4.68 | 16.92 | 8.03 | -12.01 | 13.97 |
| Siegfried Holding AG | 1.28bn | 128.23m | 5.24bn | 3.80k | 38.90 | 5.50 | 24.46 | 4.08 | 29.87 | 29.87 | 299.09 | 211.39 | 0.7046 | 2.00 | 3.80 | 326,556.30 | 7.06 | 6.51 | 8.64 | 7.98 | 25.87 | 23.24 | 10.03 | 9.06 | 1.40 | 14.34 | 0.3217 | 15.26 | 3.41 | 9.87 | -28.16 | 18.34 | 17.95 | 6.72 |
| Financiere de Tubize SA | 0.00 | 173.09m | 5.47bn | -- | 31.62 | 3.08 | 31.62 | -- | 4.13 | 4.13 | 0.00 | 42.45 | 0.00 | -- | -- | -- | 9.64 | 7.04 | 9.85 | 7.24 | -- | -- | -- | 145.70 | -- | -- | 0.0161 | 20.94 | -- | -- | 3.50 | -20.93 | -- | 11.61 |
| Ono Pharmaceutical Co Ltd | 2.98bn | 719.50m | 5.66bn | 3.85k | 7.53 | 1.11 | 6.84 | 1.90 | 253.57 | 253.57 | 1,052.07 | 1,726.26 | 0.5117 | 2.44 | 3.65 | 129,855,200.00 | 12.38 | 11.95 | 15.14 | 13.73 | 74.69 | 74.11 | 24.20 | 23.89 | 1.32 | -- | 0.1661 | 32.25 | 12.41 | 11.73 | 13.53 | 19.95 | -6.79 | 12.20 |
| Jazz Pharmaceuticals PLC | 3.31bn | 334.56m | 5.84bn | 2.80k | 19.16 | 1.83 | 6.59 | 1.76 | 5.82 | 5.82 | 57.26 | 60.94 | 0.3457 | 0.6914 | 5.98 | 1,396,387.00 | 3.51 | 1.48 | 3.94 | 1.62 | 89.39 | 88.79 | 10.14 | 4.26 | 2.02 | 2.27 | 0.6027 | 0.00 | 4.78 | 15.19 | 285.14 | -1.49 | -20.04 | -- |
Data as of Sep 18 2024. Currency figures normalised to Siegfried Holding AG's reporting currency: Swiss Franc CHF
23.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Sep 2024 | 157.19k | 3.48% |
| Dimensional Fund Advisors LPas of 05 Sep 2024 | 142.90k | 3.17% |
| BlackRock Fund Advisorsas of 12 Sep 2024 | 135.39k | 3.00% |
| Z�rcher Kantonalbank (Investment Management)as of 31 Dec 2023 | 132.98k | 2.95% |
| Credit Suisse Asset Management (Schweiz) AGas of 19 Feb 2024 | 129.57k | 2.87% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 108.46k | 2.40% |
| UBS Asset Management Switzerland AGas of 29 Aug 2024 | 94.62k | 2.10% |
| Brock Milton Capital ABas of 25 Jul 2024 | 90.57k | 2.01% |
| DWS Investment GmbHas of 31 Jul 2024 | 34.58k | 0.77% |
| AXA Investment Managers (Paris) SAas of 30 Aug 2024 | 31.61k | 0.70% |
More ▼
Data from 30 Jun 2024 - 25 Jul 2024Source: FactSet Research Systems Inc.
